General Information of Drug (ID: DMOIKB3)

Drug Name
5-Hydrazino-1H-tetrazole Drug Info
Synonyms
5-Hydrazino-1H-tetrazole; 5-hydrazinyl-1H-tetrazole; FXYYVODGZXUHLT-UHFFFAOYSA-N; 5-hydrazinotetrazole; AC1LA0KS; 2H-tetrazol-5-ylhydrazine; 1H-tetrazol-5-ylhydrazine; SCHEMBL94795; CTK7F1894; ZX-AN011348; ALBB-012551; NSC206227; STL421139; AKOS000295392; ZINC100158257; NSC-206227; 1H-1,2,3,4-Tetrazole, 5-hydrazino-; 1H-tetrazole, 5-hydrazino-, hydrochloride; BB 0259716
Cross-matching ID
PubChem CID
459489
CAS Number
CAS 40925-73-3
TTD Drug ID
DMOIKB3

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AKOS003197197 DM0P2U3 N. A. N. A. Patented [1]
Hydrazinoacetic acid DMEQBTO N. A. N. A. Patented [1]
propargylglycine DMVRWL6 Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cystathionine gamma-lyase (CTH) TTLQUZS CGL_HUMAN Inhibitor [1]

References

1 Cystathionine--lyase (CSE) inhibitors. US9725426.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1444).